GlassScriptPhysician profile
Median Ali
NPI 1649253113
$8,500.96
in general payments reported to CMS, 2019-2025
8 companies · $4,596 in 2025
The $4,596 reported for 2025 was more than what 92% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.40 · 2023: $72.51 · 2024: $3,812 · 2025: $4,596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,000 · Travel and Lodging: $1,281 · Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,000.00 |
| Travel and Lodging | $1,281.34 |
| Food and Beverage | $199.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,298.33 | 2024-2025 | |
| Glaxosmithkline, LLC. | $73.92 | 2023-2025 | Trelegy Ellipta, Arexvy |
| Pulmonx Corporation | $29.96 | 2025 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.72 | 2025 | Ofev |
| Shionogi INC | $20.40 | 2022 | |
| Philips North America LLC | $19.39 | 2023 | |
| United Therapeutics Corporation | $15.24 | 2023 | Tyvaso |
| Astrazeneca Pharmaceuticals LP | $14.00 | 2023 | Breztri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Median Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.